Cancer drugs - A pratical approach to drugs available to us (Broché)

Edition en anglais

  • Eska (Editions)

  • Paru le : 03/03/2014
Note moyenne : |
Ce produit n'a pas encore été évalué. Soyez le premier !
Donnez votre avis !
What do doxorubicin and adriamycin have in common? Why can the indications for platinum compounds vary so much? Have monoclonal antibodies ousted cytotoxic... > Lire la suite
35,00 €
Neuf - Expédié sous 3 à 6 jours
  • ou
    Livré chez vous
    entre le 27 février et le 1 mars
ou
Votre note
What do doxorubicin and adriamycin have in common? Why can the indications for platinum compounds vary so much? Have monoclonal antibodies ousted cytotoxic drugs? What is an anticancer antibiotic? The aim of this book is to answer these questions, and all those that arise from being in contact with cancer drugs. To do this, we first need to classify each one in relation to the others. Each product is then described, detailing its official indications, as validated by its marketing license, then its dose, its mode of administration and the precautions that need to be taken when using it, any eventual resistance it may generate, and finally, the side effects it may cause.
  • Date de parution : 03/03/2014
  • Editeur : Eska (Editions)
  • ISBN : 978-2-7472-2044-6
  • EAN : 9782747220446
  • Présentation : Broché
  • Poids : 0.578 Kg
  • Dimensions : 16,0 cm × 24,0 cm × 1,9 cm

Biographie de Jean Trédaniel

Jean TREDANIEL is a Professor of Oncology at Paris-Descartes University. He leads the thoracic cancerology unit of the Paris Saint-Joseph Hospital Group.

Nos avis clients sur decitre.fr


Avis Trustpilot
Jean Trédaniel - Cancer drugs - A pratical approach to drugs available to us.
Cancer drugs. A pratical approach to drugs available...
35,00 €
Decitre utilise des cookies pour vous offrir le meilleur service possible. En continuant votre navigation, vous en acceptez l'utilisation. En savoir plus OK